Core Viewpoint - Harbin Air Conditioning (哈空调) is attempting to divest its underperforming subsidiary, Harbin Fushanchuan Biotechnology Development Co., Ltd. (富山川), to streamline operations amid financial pressures and a need for transformation [1][2] Group 1: Asset Divestiture - The company plans to publicly transfer 40% of its stake in Fushanchuan at a minimum price of 3.8126 million yuan, based on an assessed value [2][3] - Fushanchuan has ceased operations and is currently in a "dormant state," with a reported net loss of 16.0963 million yuan for 2024, which is 218.83% of Harbin Air Conditioning's previous year's net profit [2][3] - The valuation of Fushanchuan shows a 7.69% increase from its book value, with total equity assessed at 9.5314 million yuan [2] Group 2: Financial Challenges - Harbin Air Conditioning's revenue for the first three quarters of 2025 was 827 million yuan, a year-on-year decrease of 12.19%, with a net loss of 23.8215 million yuan [3] - Fushanchuan has been listed as a dishonest executor, with its bank accounts frozen due to legal disputes, and it is involved in multiple contract disputes that have led to additional financial liabilities [4] - The company has an outstanding unfulfilled capital contribution of 15.4718 million yuan related to its investment in Fushanchuan, which poses a financial risk [4][5] Group 3: Internal Financial Obligations - Fushanchuan owes Harbin Air Conditioning approximately 19.7955 million yuan in various internal debts, with no clear repayment plan provided [5] - The other shareholders of Fushanchuan have waived their right of first refusal on the share transfer, necessitating Harbin Air Conditioning to seek external buyers [5] - The company has acknowledged the uncertainty surrounding the success of the transaction and the final terms of the sale [5]
标的失信+经营停摆+欠款!哈空调拟381万元底价挂牌富山川40%股权